222 related articles for article (PubMed ID: 25188770)
1. Nystatin prophylaxis and treatment in severely immunodepressed patients.
Gøtzsche PC; Johansen HK
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD002033. PubMed ID: 25188770
[TBL] [Abstract][Full Text] [Related]
2. Nystatin prophylaxis and treatment in severely immunodepressed patients.
Gøtzsche PC; Johansen HK
Cochrane Database Syst Rev; 2002; (4):CD002033. PubMed ID: 12519566
[TBL] [Abstract][Full Text] [Related]
3. Nystatin prophylaxis and treatment in severely immunodepressed patients.
Gøtzsche PC; Johansen HK
Cochrane Database Syst Rev; 2002; (2):CD002033. PubMed ID: 12076436
[TBL] [Abstract][Full Text] [Related]
4. Nystatin prophylaxis and treatment in severely immunodepressed patients.
Gotzsche PC; Johansen HK
Cochrane Database Syst Rev; 2000; (2):CD002033. PubMed ID: 10796846
[TBL] [Abstract][Full Text] [Related]
5. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.
Cortegiani A; Russotto V; Maggiore A; Attanasio M; Naro AR; Raineri SM; Giarratano A
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD004920. PubMed ID: 26772902
[TBL] [Abstract][Full Text] [Related]
6. Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
Jørgensen KJ; Gøtzsche PC; Dalbøge CS; Johansen HK
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD004707. PubMed ID: 24563222
[TBL] [Abstract][Full Text] [Related]
7. Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients.
Johansen HK; Gøtzsche PC
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD000239. PubMed ID: 25188769
[TBL] [Abstract][Full Text] [Related]
8. Routine versus selective antifungal administration for control of fungal infections in patients with cancer.
Gøtzsche PC; Johansen HK
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD000026. PubMed ID: 25188768
[TBL] [Abstract][Full Text] [Related]
9. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.
Playford EG; Webster AC; Sorrell TC; Craig JC
Cochrane Database Syst Rev; 2006 Jan; (1):CD004920. PubMed ID: 16437504
[TBL] [Abstract][Full Text] [Related]
10. Antifungal agents for preventing fungal infections in solid organ transplant recipients.
Playford EG; Webster AC; Sorell TC; Craig JC
Cochrane Database Syst Rev; 2004; (3):CD004291. PubMed ID: 15266524
[TBL] [Abstract][Full Text] [Related]
11. Voriconazole versus amphotericin B in cancer patients with neutropenia.
Jørgensen KJ; Gøtzsche PC; Johansen HK
Cochrane Database Syst Rev; 2006 Jan; (1):CD004707. PubMed ID: 16437492
[TBL] [Abstract][Full Text] [Related]
12. Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections.
Blyth CC; Hale K; Palasanthiran P; O'Brien T; Bennett MH
Cochrane Database Syst Rev; 2010 Feb; 2010(2):CD006343. PubMed ID: 20166083
[TBL] [Abstract][Full Text] [Related]
13. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.
Pienaar ED; Young T; Holmes H
Cochrane Database Syst Rev; 2006 Jul; (3):CD003940. PubMed ID: 16856025
[TBL] [Abstract][Full Text] [Related]
14. Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials.
Playford EG; Webster AC; Sorrell TC; Craig JC
J Antimicrob Chemother; 2006 Apr; 57(4):628-38. PubMed ID: 16459344
[TBL] [Abstract][Full Text] [Related]
15. Amphotericin B vs fluconazole for controlling fungal infections in neutropenic cancer patients.
Johansen HK; Gotzsche PC
Cochrane Database Syst Rev; 2000; (3):CD000239. PubMed ID: 10908468
[TBL] [Abstract][Full Text] [Related]
16. Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients.
Johansen HK; Gøtzsche PC
Cochrane Database Syst Rev; 2002; (2):CD000239. PubMed ID: 12076388
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic oral antifungal agents to prevent systemic candida infection in preterm infants.
Austin NC; Darlow B
Cochrane Database Syst Rev; 2004; (1):CD003478. PubMed ID: 14974017
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.
Austin N; Darlow BA; McGuire W
Cochrane Database Syst Rev; 2009 Oct; (4):CD003478. PubMed ID: 19821309
[TBL] [Abstract][Full Text] [Related]
19. Routine versus selective antifungal administration for control of fungal infections in patients with cancer.
Gotzsche PC; Johansen HK
Cochrane Database Syst Rev; 2000; (4):CD000026. PubMed ID: 11034669
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.
Clerihew L; Austin N; McGuire W
Cochrane Database Syst Rev; 2007 Oct; (4):CD003850. PubMed ID: 17943803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]